[TAFI plasma levels are not increased in patients with venous thromboembolic disease and factor V Leiden or prothrombin 20210A mutations].
Verdú Belmar
José
J
Marco Vera
Pascual
P
García Hernández
Carmen
C
Lucas Boronat
Javier
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D025861:Blood Coagulation Disorders, Inherited / Q000097:blood / Q000150:complications / Q000235:genetics*; D025901:Carboxypeptidase B2 / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D016022:Case-Control Studies; D005165:Factor V / Q000032:analysis / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017354:Point Mutation; D011516:Prothrombin / Q000032:analysis / Q000235:genetics*; D020246:Venous Thrombosis / Q000097:blood / Q000235:genetics*
C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin; D025901:Carboxypeptidase B2